Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer.

@article{Mansi2004NuclearMI,
  title={Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer.},
  author={L. S. A. Mansi and Roy Moncayo and Vincenzo Cuccurullo and Massimo Eugenio Dottorini and Pierfrancesco Rambaldi},
  journal={The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...},
  year={2004},
  volume={48 2},
  pages={
          82-95
        }
}
Diagnostic strategy in thyroid cancer is conditioned by epidemiological, pathophysiological, cost-effective issues changing with age and countries. Nuclear medicine has a role mainly in differentiated carcinomas, i.e. in the large majority of thyroid cancers. In diagnosis of thyroid nodule (99m)Tc-perthecnetate is indicated in patients with low TSH levels, multinodular goiter, solid nodules at US negative at FNA. Radiolabeled somatostatin analogs or Metaiodobenzylguanidine (MIBG) can be used in… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 125 REFERENCES

Terapia radiometabolica della patologia tiroidea

  • G Lucignani, A Del Sole, M Lecchi, E. Bombardieri
  • Idelson Ed. .p.261-98
  • 2004

Similar Papers

Loading similar papers…